2) These researchers had previously done a mouse experiment where SARS-CoV-2 spike (S1) protein in the nasal cavity caused fatigue- and depression-like symptoms and reduced acetylcholine.
Symptoms were improved with the drug donepezil (an acetylcholinesterase inhibitor)